SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Laboratories informs about outcome of board meeting

23 Oct 2024 Evaluate

In connection with the Board Meeting intimation dated October 17, 2024, Zenotech Laboratories has informed that the meeting of the Board of Directors of the Company was held today October 23, 2024 which commenced at 11:30 am and ended at 2:45 pm IST. The Board of Directors of the Company has: 1) Approval of unaudited standalone financial results for the quarter and half year ended September 30, 2024: Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the unaudited standalone financial results of the Company for the quarter and half year ended September 30, 2024, along with Limited Review Report issued by the Statutory Auditors of the Company, are enclosed as Annexure A. 2) Appointment of Chief Executive Officer (Key Managerial Personnel) of the Company: Based on the recommendation of Nomination and Remuneration Committee, the Board had appointed Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) of the Company with immediate effect. Brief details about Sachin Laxmanappa Gavandare as required in compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, pertaining to his appointment are disclosed hereunder as Annexure B.

The above information is a part of company’s filings submitted to BSE.

Zenotech Laboratorie Share Price

47.24 -2.15 (-4.35%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×